saplin

Compare funds

SBI Large & Midcap vs Motilal Oswal Large and Midcap

Both are large & mid cap funds. Over the last 3 years SBI Large & Midcap returned 13.7% a year and Motilal Oswal Large and Midcap 21.2%, against a category median of 14.7%. SBI Large & Midcap costs 0.86% a year and Motilal Oswal Large and Midcap 0.91%. On the saplin Score SBI Large & Midcap rates 7.0 (Neutral) and Motilal Oswal Large and Midcap 7.5 (Neutral) within their category. 2.8% of their money is in the same stocks.

Direct plans, growth option. Returns and risk as of 15 Nov 2026; past performance does not tell you future returns. See both side by side with charts.

At a glance

SBI Large & MidcapMotilal Oswal Large and MidcapCategory median
saplin Score (0–10)7.0 Neutral7.5 Neutral—
1-year return1.3%8.9%3.9%
3-year return, a year13.7%21.2%14.7%
5-year return, a year12.4%18.1%12.2%
Volatility (standard deviation)14.2%21.8%16.4%
Sharpe ratio0.540.740.53
Beta0.841.130.96
Upside capture89135101
Downside capture8011698
Expense ratio (Direct)0.86%0.91%1.06%
Fund size₹41,910 cr₹19,305 cr₹4,177 cr
Number of holdings863370
Top 10 holdings, share of fund30.0%42.6%33.0%
Portfolio P/E25.944.828.9
Lead managerSaurabh Pant (10 yrs)——
Launched28 Feb 199327 Sept 2019—

Green marks the higher return, Sharpe ratio, upside capture and Score, and the lower volatility, downside capture and cost. That is the direction of each measure, not a recommendation.

Portfolio overlap

SBI Large & Midcap and Motilal Oswal Large and Midcap have 2.8% of their portfolios in the same stocks (2 holdings in common, portfolios as of 31 Oct 2026). Overlap is the smaller of the two weights in each shared holding, added up: 100% would be identical portfolios.

Biggest shared holdingsSBI Large & MidcapMotilal Oswal Large and Midcap
Divi's Laboratories2.04%2.81%
Samvardhana Motherson International0.79%2.42%

The funds

How the Score works: methodology. Check any set of funds with the overlap checker.

More comparisons

saplin is not registered with SEBI. This page compares published data and is not a recommendation to buy, hold or sell either fund.